Academic conference presentation
1.
2026/10
Promoting Health Through Golf: Communicating the Value of Physical Activity
(The 18th Annual Meeting of the Japanese Association of Health Communication)
2.
2026/10
Factors Associated with Three or More Cervical Cancer Screenings among Women with Prior Screening Experience
(The 6th Annual Meeting of the Japanese Health Literacy Association)
3.
2026/10
Perceptions of Mail-Based Self-Sampling Tests (Including Finger-Prick Blood Tests) in the Netherlands: A Pilot Study Focusing on Acceptability and Feasibility
(The 18th Annual Meeting of the Japanese Association of Health Communication)
4.
2026/10
Physical Activity and Golf Scores During a Tournament for Golfers with Disabilities: An Exploratory Case Analysis of Four Golfers with Hemiparesis
(The 6th Annual Meeting of the Japanese Health Literacy Association)
5.
2026/09
Feasibility of Online Health Checkups Based on the Characteristics of Individual Examination Items in Comprehensive Health Screening Programs
(The 67th Annual Scientific Meeting of the Japan Society of Ningen Dock and Preventive Medical Care)
6.
2026/09
Factors Associated with Breast Cancer Screening Uptake
(The 67th Japan Society of Ningen Dock and Preventive Medical Care)
7.
2026/08
Effects of Imidazole Dipeptide Supplementation on Carbohydrate Oxidation During the Latter Half of Aerobic Exercise and Antioxidant Responses
(The 12th Annual Meeting of the Japanese Society of Sports Nutrition)
8.
2025/10
Digitally Vulnerable Groups: Promoting Inclusive Digital Health Literacy
9.
2025/07
Why Do Women Gather? Exploring the Real Voices of Female Golfers: Insights from a Driving Range with Over 60% Female Lesson Participation
(Seminar of the Japan Golf Range Association)
10.
2024/05
Result of the questionnaire survey on diversity, equity, and inclusion (DE & I) by the diversity promotion committee of the Japanese Society of Myeloma
11.
2020/12
Latest Evidence in Multiple Myeloma Treatment: Management of Relapsed/Refractory Multiple Myeloma
(The 17th VAMPIRE Conference)
12.
2020/07
A Hereditary bleeding disorder caused by a novel homozygous mutation of thrombomodulin gene
(ISTH Congress（Milan, Italy）)
13.
2019/12
Clinical Experience with Elotuzumab at Our Institution
(Bristol Myers Squibb Hematology Web Seminar)
14.
2019/03
Latest Evidence in Multiple Myeloma Treatment: Management of Relapsed/Refractory Multiple Myeloma
(The 15th VAMPIRE Conference)
15.
2018/12
Immunomodulatory Effects of Proteasome Inhibitors in Multiple Myeloma
(ASH 60th Annual Meeting（San Diego, USA）)
16.
2018/07
Identification of clonal evolution of CSF3R -mutated chronic neutrophilic leukemia using mutational screens of SETBP1 , ASXL1 and SRSF2
(9th JSH International Symposium（Kyoto, Japan）)
17.
2016/02
Latest Evidence in Multiple Myeloma Treatment: Management of Relapsed/Refractory Multiple Myeloma
(The 7th Verifying Anti-Myeloma Practice In pResent Era (VAMPIRE) Conference)
18.
2013/08
Primary HER2-positive lacrimal sac cancer
19.
2013/06
Plasmodium Ovale malaria in a Japanese volunteer returning from Uganda
20.
2013/03
Analysis of short-term survivors after autologous stem cell transplantation in multiple myeloma
21.
2012/10
Successful treatment of APL in a patient with hepatocellular carcinoma using arsenic trioxide
22.
2011/03
Primary amyloidosis involving congestive heart failure with 7-year survival after high-dose melphalan followed by autologous stem cell transplantation
23.
2003/03
Inhibitors of Sir2p: evaluation of Splitomicin analogues
(225th ACS National Meeting（New Orleans, USA）)
24.
2003/02
Chemical genetics of NAD+-dependent protein deacetylases
(12th Volcano Conf. in Bioorganic Chemistry（Eatonville, USA）)